Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – American Cannabis Partners Leveraging Proven Strategies to Position in US Cannabis Industry

American Cannabis Partners (“ACP”) is strengthening its position in the United States’ legal cannabis sector while keeping an eye on federal cannabis reform, which has been a roller coaster ride over the past several years. The introduction of several bills raised hopes for legislative support, especially with a change in the White House seeming to create a more cannabis-friendly atmosphere. But 2021 did not bring the much-anticipated change, and many companies operating in the space, including ACP, are looking for this year to be different. “American Cannabis Partners is eyeing the federal back-and-forth with more interest; federal change could have a significant impact on the industry, which currently operates with state-level approvals but without federal support. Yet nationwide, support for cannabis is growing,” reads a recent article. “ACP is strengthening its position in the sector, currently operating in two states – California and Michigan – that have passed legislation approving marijuana. With a total of 12 cannabis licenses, including 20,000 square feet of cultivation licenses in California and 540,000 square feet of cultivation licenses along with one retail license in Michigan, ACP is contending for first place in the U.S. cannabis industry by following proven strategies that accelerate the company’s assets, operations, expansions, and market share.”

To view the full article, visit https://cnw.fm/D2GrW

About American Cannabis Partners

American Cannabis Partners is a fully licensed, large scale and 100% organic cannabis cultivation company nationally headquartered in Trinity County of the Emerald Triangle. Guided by business professionals and cultivators, the company focuses on four industry segments: real estate, cultivation, medical research, and nonprofit groups. For both medical and recreational, American Cannabis Partners supplies multiple forms of raw product at wholesale prices for manufacturing, distribution and retail licenses. Its commodity pricing model enables stable profit margins for customers, aiding the company’s expansion into multiple states. For more information, visit the company’s website at www.ACPFarms.com.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Unions, Businesses and Groups Spend Millions Lobbying for Federal Cannabis Reforms

As more states in the U.S. legalize marijuana for medical or recreational use and the industry grows, political not-for-profit organizations, trade associations and cannabis businesses continue to lobby for cannabis reform and legalization.

Lobbyists are being paid a lot to weigh in on the cannabis reform measures being introduced in Congress, with OpenSecrets finding that 22 clients spent roughly $4.3 million last year to employ professional lobbyists to keep tabs on cannabis reform. OpenSecrets, which is a not-for-profit research group tracking political spending, found that this figure had increased from the $3.6 million recorded in 2020, noting that in the last 10 years the tally had also grown significantly.

The group found that in 2011, $35,000 was spent on lobbyists focusing on cannabis issues, with the Medical Marijuana Industry Group and the National Cannabis Industry Association accounting for this total. These tallies remained in the thousands until 2017, when stakeholders in the now-growing industry spent more than $1.5 million lobbying Congress about cannabis issues.

Since then, spending has continued increasing, with more than $15 million being spent in the period between 2018 and 2022. It’s no surprise that lobbying efforts for cannabis have increased at the federal level in the recent years, given the industry’s growth.

OpenSecrets also found that the majority of tribes, firms and organizations that spent funds on lobbyists to work on issues concerning marijuana also poured other monies into lobbying on other issues relevant to their backgrounds or businesses. This made it difficult to figure out exactly how much these stakeholders had spent on cannabis-related lobbying.

Players in the marijuana industry who spent monies lobbying Congress in 2021 include:

Pax Labs, which spent $120,000 on the SAFE Banking act and other issues related to the marijuana industry
Curaleaf Holdings, which used $280,000 to support the SAFE Banking Act, the MORE Act and other initiatives related to the federal legalization of marijuana
Holistic Industries, which spent $220,000 on issues related to social equity, banking and interstate cannabis commerce

Other businesses that spent money in 2021 on lobbying that involved marijuana and other issues include:

Morgan Stanley, which spent about $200,000 on marijuana–related banking
Amazon, which spent about $10 million on various marijuana proposals, including the Cannabis Administration and Opportunity Act and the MORE Act
Altria Client Services, which used nearly $12 million, with some of it going toward the MORE Act, the Safe Banking Act and hemp legislation

These are just a few of the many organizations and mainstream companies that are keeping tabs on marijuana activity in Congress as the marijuana industry continues to flourish and create lots of growth opportunities for licensed companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS).

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Delayed Review Leaves Canada’s Cannabis Industry in Suspense

A review of Canadian legislation that seeks to address key issues in the country’s cannabis industry has been delayed. The Cannabis Act is in need of a mandatory review that was scheduled for October 2021, three years after Canada made it legal to use marijuana for recreational purposes. According to Tammy Jarbeau, a health spokesperson, a legislative review is currently in the works.

Once the review launches, the industry seeks to address issues, some of which are not covered in the Cannabis Act. Some of those issues include excise taxes, potency limits of products, and the marketing and advertising of cannabis products. According to industry sources, the September elections, the installation of a new health minister and the pandemic are possible reasons for the review’s delay.

Last year, the Cannabis Council of Canada was in discussions with Health Canada, which wanted to narrow the review. The review is expected to have an impact on public health, Indigenous communities and legal home cultivation. George Smitherman of the Cannabis Council states that the concern of public health is important in addressing the country’s illicit market of cannabis. According to Sean Webster, an official for Ontario-based producer Canopy Growth, there are broader issues around regulations that need to be looked at in addition to the review of the mandatory issues.

The industry wants a review that will allow for an increase in the THC limit of cannabis products. According to Webster, the illegal market has products, which consumers are demanding, that claim to have more than the 10-milligram THC limit.

Health Canada’s framework on costs levied on earnings made by cannabis growers is another subject that needs to be reviewed. According to Vlad Klacar, a senior vice president at Auxly Cannabis, taxes are a burden to growers, businesses and enterprises that are still finding their way through this emerging sector. He suggests that the fees could be charged on projects or be tied to service standards.

Another concern is cannabis excise taxes, which are grouped under the Excise Act instead of the Cannabis Act. This means that the regulations come from the Department of Finance and the Canada Revenue Agency instead of Health Canada. The Ontario chambers of commerce together with British Columbia are demanding tax reforms.

It is expected that the review will end after 18 months from commencement with a report containing findings and recommendations presented to the Canadian Parliament. Webster states that the industry is ready for the review and is interested in how the process will play out. Entities such as Flora Growth Corp. (NASDAQ: FLGC), which have their eyes on an international market, are particularly interested in the review outcome.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) in the Driver’s Seat Across One of the Country’s Largest, Fastest-Growing Cannabis Markets

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently announced it had received all regulatory approvals and closed its acquisition of PharmaCo, a Michigan-based marijuana company. This acquisition expands RWB’s footprint within the state, having initially only had a single product line in this market – the Platinum Vape(R) brand. Following the acquisition, RWB now controls all aspects of its Michigan operations. “This successful acquisition gives RWB access to 22 owned properties, including nine dispensaries and three cultivation sites in Glendale, Marquette and Au Gres… Going forward, RWB looks to execute its initiatives that include extending its branded product lines, updating its dispensaries to heighten the customer experience, creating supply chain efficiencies, and growing revenue and profitability. This is possible given the company now controls all Michigan operations, from growing the product to selling it,” a recent article reads. “We are now in the driver’s seat on over 20 assets across Michigan – one of the largest and fastest-growing cannabis markets in the country,” said RWB CEO and Chairman Brad Rogers.

To view the full article, visit https://cnw.fm/6RGS2

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Positioned to Help Meet Needs of New USDA Initiative

Advanced Container Technologies (OTC: ACTX) today announced it is ideally suited to help meet the needs of the new USDA initiative to build a new and more equitable food system. The “Build Back Better Food System Transformation Initiative” is designed to expand access to nutritious food in rural, tribal and other areas that are currently underserved. ACTX can be an integral part of this effort through providing GrowPods — transportable controlled environment farms. The pods enable cultivation to be moved directly into the areas where food is needed. In addition, locating GrowPods nearer to the point of consumption allows food to be harvested at its peak nutritional value and greatly reduces the carbon and environmental impact of the nation’s current food chain, which relies on trucks carrying mass quantities of produce across the country.

To view the full press release, visit https://cnw.fm/ils4T

About Advanced Container Technologies Inc.

Advanced Container Technologies is the exclusive distributor of GrowPods (controlled environment farms) in certain markets. For more information on GrowPods or Advanced Container Technologies, call (951) 381-2555 or visit www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Online Article on Former President Clinton’s Favorable Comments on CBD Deleted

Cannabis is one of the most polarizing topics in America. While some wrongly believe that the controversial drug inevitably leads to addiction and criminal activity, others are appalled that millions of Americans have had their lives disrupted by what they see as draconian prohibition rules targeting a benign substance.

With the White House, Senate and Congress in the hands of the Democrats, marijuana policy has become even more of a hot topic. A now-deleted news report from Cannabis & Tech Today stated that even former president Bill Clinton had heard about CBD’s potential as an alternative medicine.

The article was based on a conversation Clinton had at the Impact Forum in Orlando with Sanjay Gupta, CNN’s chief medical expert. He was quoted saying that there is some evidence of CBD’s ability to relieve pain. In fact, a large number of CBD users say that they first turned to the cannabinoid to help relieve pain, and a 2019 poll found that 40% of CBD users say they use it for pain relief.

However, the story was taken down after Cannabis & Tech Today was allegedly pressured by the former president’s PR team. An editor from the online publication told Marijuana Moment that while the story, written by journalist Sara Brittany Somerset, was quoted “accurately and live,” the company took it down after Clinton’s public relations team said his comments at the Impact Forum weren’t open to the media.

When asked for a comment, an Impact Forum representative said that the event was private and the organization does not provide audio, video or transcripts. She said that the panel did not give any press authorization to attend and that it could not verify the quotes included in the story or confirm how the content was obtained.

Nonetheless, Cannabis & Tech Today said it didn’t want to retract the story and that it stood by the quotes included in the now-deleted story. However, the publication choose to respect the request from Clinton’s PR team and take the story down. Clinton allegedly said that he’d heard from many people about how low-THC cannabis could help manage chronic pain and that he receives tons of messages about CBD all the time. He said that there was some evidence that CBD with little to no THC has the ability to combat pain.

Clinton’s comments are quite interesting as his administration consistently opposed efforts to reform cannabis policy and even took a stance against medical marijuana, threatening to revoke the prescribing licenses of doctors who recommended state legal medical marijuana.

The change in the views of former POTUS Clinton reflects the growing scientific data contradicting the assertion by the DEA that cannabis and its compounds as contained in the products of state-licensed businesses such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) have no therapeutic benefit and have a high potential for being abused, hence their current Schedule 1 status. This position is collapsing in the wake of scientific scrutiny.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Cannabis and Civil Rights Reformers Want Legalization Bill Voted on in March

Last week, cannabis advocacy groups joined with civil rights groups to come together through a coalition and address the U.S.House. Through a letter, the groups called for a floor vote on a bill this month that would legalize cannabis on a federal level as well as promote equity.

More than 20 organizations, including the National Urban League, American Civil Liberties Union and Human Rights Watch, came together under the Marijuana Justice Coalition (“MJC”). The coalition has mentioned that reform is needed since vote delay will lead to an increase in incarceration rates for cannabis-related offenses.

The bill in discussion is the Marijuana Opportunity, Reinvestment and Expungement (“MORE”) Act. It is sponsored by Rep. Jerrold Nadler (D-NY) and was passed by the House in December 2020, yet no advancements have been made.

For every passing minute, one person in the United States is arrested for a cannabis-related offense that is minor. According to the letter written to House Majority Leader Steny Hoyer (D-MD) and House Speaker Nancy Pelosi (D-CA), the public needs to know whether Congressional members stand on the side of justice and are against an outdated policy that prohibits and criminalizes cannabis. As a result of mass criminalization, the enforcement of these regulations has greatly affected the socioeconomic fabrics of communities, particularly those of Black, Latino and Indigenous people.

Apart from the removal of marijuana from the Controlled Substances Act, the bill aims to reduce the rate of mass incarcerations as well as remove financial obstacles that prevent small businesses from operating in the cannabis economy.

The letter also mentioned public opinion on marijuana, noting that many Americans feel that marijuana should no longer be federally prohibited. The letter stated that the federal government needed to catch up with the culture shift that favors marijuana regulatory reform, urging government leaders to bring the bill to the House in March.

Some of the other signatories that wrote the letter included NORML, Center for American Progress, Drug Policy Alliance, BOWL PAC, Students for Sensible Drug Policy, Doctors for Cannabis Regulation, Immigrant Legal Resource Center, MoveOn, Leadership Conference on Civil & Human Rights, United Food and Commercial Workers International Union, Lawyers’ Committee for Civil Rights Under Law and Veterans’ Cannabis Coalition.

Another bill that the advocates are following is the Cannabis Administration & Opportunity Act (“CAOA”). This bill is sponsored by Senate Majority Leader Chuck Schumer (D-NY), Sen. Cory Booker (D-NJ) and Finance Committee Chair Ron Wyden (D-OR); the bill is expected to be filed in April.

The federal legalization of marijuana would give industry actors such as American Cannabis Partners a huge opportunity to expand rapidly into different parts of the country without having to navigate a patchwork of often-contradictory regulations for each target jurisdiction.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Award for Oral Nicotine Compound Patent

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has been granted an Australian patent titled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof.” The patent expands Lexaria’s world patent portfolio to 24. According to the announcement, the patent expands the company’s international intellectual property rights to apply its proprietary DehydraTECH(TM) enhancement technology to most oral forms of nicotine delivery, which would include pills, tablets, lozenges, capsules, pouches, gums and sprays. In addition to covering different forms of delivery, the patent also includes an array of nicotine forms, such as free base nicotine, nicotine salts, polymer resins of nicotine and other forms of nicotine complexes. This is the first patent awarded from LEXX’s eighth patent family; a first patent in a new patent family often leads to additional patents granted in that same family. Lexaria noted that it has pending patent applications in other countries, including the United States. The company also noted nine patent claims have been granted the government of Australia.

To view the full press release, visit https://cnw.fm/wCEJf

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption with cannabinoids and nicotine by 5 to 10 times — and in some instances with cannabinoids by as much as 27 times — compared to standard industry formulations, as well as reduce time of onset from one to two hours to minutes and mask unwanted tastes. The delivery systems are also being evaluated for orally administered, anti-viral drugs; nonsteroidal, anti-inflammatory drugs (“NSAIDs”); PDE5 inhibitors; and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and more than 50 patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Cannabis Companies in Germany Attract Investments as Nation Gears Up for Recreational Sales

Cannabis startups in Germany are experiencing an uptake in investment funding as they look to capitalize on the potential of legalization of recreational marijuana. This comes as the sector of medical marijuana, which is legal, is experiencing tremendous growth.

Investment funding in the cannabis sector experienced a slow growth in 2020 before regaining its momentum last year. According to Stephen Murphy, the CEO and cofounder of marijuana research firm Prohibition Partners, this year has begun with a positive start as investors position themselves to benefit from the burgeoning market.

Additionally, investors are looking forward to the legalization of recreational marijuana in Germany. The ruling coalition has made promises, but its legalization appears not to be close at hand. Canadian and American businesses that have their business operations in Europe are also positioning themselves to gain from an expanding recreational market.

Cansativa Group, a startup based in Frankfurt, has raised $15 million in a Series B funding round that was led by Snoop Dogg-backed investment company Casa Verde Capital. According to its cofounder Benedikt Sons, this round provided better results in comparison to the first one. The company is the only distributor of cannabis that is cultivated in Germany.

Another startup, Sanity Group, has received $3.5 million from Casa Verde in a financing round. The company is based in Berlin and focuses on medical marijuana. So far, it has managed to raise more than $76 million. According to founder and managing director Finn Hänsel, this is a record in funding a cannabis startup in Europe.

The legalization of medical marijuana in 2017 is responsible for the boom in startups. Companies such as Cansativa, Sanity Group, Cantourage and Demecan rose during this time. However, investors have been reluctant to back them until last year when the ruling coalition pledged to legalize the recreational use of marijuana.

Investors are hopeful that Germany’s stance would work in destigmatizing cannabis elsewhere with more countries following suit. Germany already is Europe’s largest market for medical cannabis. Last year, insurance compensations for medical marijuana saw a 9% increase in comparison to 2020 as the total amount reached almost $17 million.

The marijuana research firm Prohibition Partners estimates that Europe’s annual sales of medical cannabis stands at $270 million. The firm estimates that if Germany legalizes the recreational use of cannabis, sales figures are estimated to reach up to $4 billion every year.

For this to be possible, lawmakers must create regulations around its cultivation, production and distribution as well as sales and marketing. According to Jacob Sons, the cofounder of Cansativa, the legislation, which is in its early stages, will provide a blueprint to the region.

These developments in Germany are likely to be of great interest to internationally focused companies such as Flora Growth Corp. (NASDAQ: FLGC) as new markets could open up and offer expansion opportunities.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Local Authorities in California Start Granting Tax Relief to Cannabis Businesses

Local governments in the state of California are granting tax relief to marijuana businesses after state legislators failed to lower cannabis taxes. The tax rollbacks by counties and cities primarily reflect lobbying from local businesses and residents as well as industry organizations.

The local governments have argued that taxing the industry at all levels of the supply chain is strengthening the illegal cannabis market while also making it hard for marijuana companies to stay afloat and conduct their business. Various localities including the counties of Sonoma and Humboldt and the cities of San Diego and Desert Hot Springs are a few that have granted tax relief to businesses participating in this burgeoning industry.

This comes after California’s wholesale marijuana prices dropped in 2021 because of a supply glut. Prices started rebounding recently. The rollbacks also come in the midst of accusations from industry insiders, local legislators and operators that the state hasn’t done as much as it could to properly address tax reform. Currently, cannabis license holders in the state are subject to a cultivation tax of $161 per pound. They are also subject to a 15% excise tax as well as other taxes levied by county and city officials.

At the start of this year, California Gov. Gavin Newsom vowed to address tax reform. Since then, a number of measures that address marijuana taxation have been introduced, including SB 1293, SB 1281, AB 2506 and AB 2792. Of these bills, Senate Bill 1281 is the most comprehensive. It would do away with the state cultivation tax and decrease the excise tax to 5%.

However, even with the obvious need for relief, these legislative actions may not take effect until 2023, which is why localities are taking charge. Localities that are considering or have implemented marijuana tax relief and reductions include Humboldt County, which reduced the county’s cultivation tax by 85% last month. This temporary reduction in cultivation tax demonstrates its commitment to cultivators who have committed millions to Humboldt’s economy in the last few years.

In January, the Board of Supervisors in Sonoma County also voted to put off the payment of taxes imposed in the first quarter of this year until the end of April. The taxes levied will be due without interest or penalties.

The Board of Supervisors in Monterey County may soon vote to reduce cultivation tax in the jurisdiction while the city council of Cloverdale also plans to decrease tax rates for all licensees.

As efforts to reform the tax policies surrounding marijuana gather steam, licensed companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) could soon dent the illicit marijuana market that has partly been helped by legal products that are too costly, which pushes consumers to the black market.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.